Futura’s Revolutionary ED Treatment One Step Closer To US And EU OTC Approval
Executive Summary
US and EU OTC approval for Futura's drug-free erectile dysfunction treatment MED3000 edges closer, following the company's submission of its EU dossier and a second pre-submission meeting with the FDA.
You may also be interested in...
Futura’s Drug-Free Erectile Dysfunction Gel On Track For US And EU Launch
Futura Medical's latest meeting with the FDA puts the UK start-up one step closer to launching its drug-free erectile dysfunction gel MED3000 in the US in 2023, while the firm gets ready to launch in the EU next year following its recent CE-mark approval.
Pfizer's Upjohn Breaking The Silence Around ED With New Viagra Connect Campaign In UK
Pfizer is investing roughly $10m in Viagra Connect in the UK to help raise awareness of erectile problems among the country's male population.
Watch Out Viagra! UK’s Futura Set To Shake Up Global ED Market With MED3000
HBW Insight talks exclusively to Futura Medical about its new erectile dysfunction product MED3000, which it says could take the global OTC market by storm.